Accordingly, the impaired action of insulin in type 2 diabetes leads to reduced plasma triglyceride clearance, which in turn contributes to elevated post-prandial lipid excursions and fasting dyslipidemia [59]. The gene discussed is INS; the disease is type 2 diabetes mellitus.